10E8.4/iMab

BIOLOGICAL2 trials

Sponsors

David Ho

Conditions

HIV-1-infection

Phase 1

10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults

CompletedNCT03875209

David HoHIV-1-infection

Start: 2019-04-08End: 2022-03-23Updated: 2023-03-07

10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults

Active, not recruitingNCT05890963

David HoHIV-1-infection

Start: 2023-11-28End: 2027-05-31Updated: 2025-04-25

Related Papers

Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS

JCI Insight2024-04-076 citations